Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

scientific article

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1200/JCO.2006.06.8429
P698PubMed publication ID17075117

P50authorEric Van CutsemQ37068027
Jaffer AjaniQ64913003
P2093author name stringCorrado Boni
Yee Chao
Edouard Voznyi
Sergei Tjulandin
Vladimir M Moiseyenko
Manuel Constenla
Miguel Fodor
Marie-Laure Risse
Adriano Rodrigues
Alejandro Majlis
V325 Study Group
P433issue31
P407language of work or nameEnglishQ1860
P921main subjectfluorouracilQ238512
cisplatinQ412415
docetaxelQ420436
P304page(s)4991-4997
P577publication date2006-11-01
P1433published inJournal of Clinical OncologyQ400292
P1476titlePhase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group
P478volume24